- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04949360
SleepUp Digital CBTi-based Platform for Insomnia
Evaluation of SleepUp Digital CBTi-based Platform in the Treatment of Insomnia
Cognitive-Behavioral Therapy for insomnia (CBTi) is a well-established therapeutic intervention for insomnia. SleepUp provides a digital therapeutics platform based on CBTi and additional features. This clinical trial aims at analyzing the efficacy of the CBTi-based platform offered by SleepUp in reducing symptoms of insomnia.
The sample will be composed of 160 individuals, both males and females, from 20 to 60 years old, with insomnia symptoms considered as at least mild. Those who accept to participate will be randomized and distributed in four groups:
- Standard CBTi (CBTi-S): This treatment consists of an eight-week treatment composed by weekly and structure appointments with board-certified sleep psychologists. The appointments will be made remotely (video calls with psychologists).
- Minimal intervention - Sleep hygiene (MI-SH): This group informative material regarding normal sleep pattern and sleep hygiene (through regular mail and e-mail). This procedure is more adequate as a control than the commonly used no treatment or waiting list controls, due to the behavioral nature of insomnia.
- Online CBTI (CBTI-O): This group will receive access to an eight-month CBTi-based treatment through the SleepUp app. The platform will be updated into a non-commercial version, and all features other than the CBTi track, the sleep log and the clinical tests will be removed. This way, the participants of this group will receive interventions equivalent to the standard in-person CBTi, but provided through a digital platform. The treatment last eight weeks.
- Online CBTi + additional features (CBTi-O+): This group will have access to the complete premium version of SleepUp platform. It includes those presented in the CBTi-O group and other therapeutic and complementary features (including meditation audios and videos, mindfulness therapy, relaxation soundtracks, sleep hygiene tips, virtual assistant, and telehealth.
All participants in all groups will be assessed periodically throughout the eight weeks of intervention with standard sleep questionnaires and sleep logs. Additionally, follow ups will be made at two, four and six months after the end of the intervention. Equivalent intervals will be applied to the SH-MI group.
Study Overview
Status
Conditions
Detailed Description
Cognitive-Behavioral Therapy for insomnia (CBTi) is a well-established therapeutic intervention for insomnia. In its standard presentation, it is composed by 6 to 12 weekly appointments with a board-certified sleep psychologist. SleepUp provides a digital therapeutics platform based on CBTi and additional features. This clinical trial aims at analyzing the efficacy of the CBTi-based platform offered by SleepUp in reducing symptoms of insomnia.
The participants will be recruited based on SleepUp's records and database and invited to participate. Those participants who are eligible in accordance to the inclusion and exclusion criteria will be contact by a member of the research team who will provide a consent form and will explain the terms and conditions of this research project. The sample will be composed of 160 individuals, both males and females, from 20 to 60 years old, with insomnia symptoms considered as at least mild, according to the Insomnia Severity Index (ISI). All groups shall have similar proportions of gender and of insomnia symptoms severity. Those who accepted to participate will be randomized and distributed in four groups:
- Standard CBTi (CBTi-S): This is a positive control group, in which standard CBTi (the golden standard behavioral treatment for insomnia) will be made available. This treatment consists of an eight-week treatment composed by weekly and structure appointments with psychologists. Only psychologists board-certified in sleep medicine will perform the CBTi sessions, and none of them are part of the research team. Due to the restriction imposed by the COVID-19 pandemic, the appointments will be made remotely (video calls with psychologists), which have already been proven to be equivalent to the in-person CBTi.
- Minimal intervention - Sleep hygiene (MI-SH): This group corresponds to a negative control group, subjected to minimal intervention. It is based on the delivery of informative material regarding normal sleep pattern and sleep hygiene (through regular mail and e-mail). This procedure is more adequate as a control than the commonly used no treatment or waiting list controls, due to the behavioral nature of insomnia.
- Online CBTI (CBTI-O): This group will receive access to an eight-month CBTi-based treatment through the SleepUp app. The platform will be updated into a non-commercial version, and all features other than the CBTi track, the sleep log and the clinical tests will be removed. This way, the participants of this group will receive interventions equivalent to the standard in-person CBTi, but provided through a digital platform. The treatment last eight weeks.
- Online CBTi + additional features (CBTi-O+): This group will have access to the complete premium version of SleepUp platform. It includes those presented in the CBTi-O group and other therapeutic and complementary features (including meditation audios and videos, mindfulness therapy, relaxation soundtracks, sleep hygiene tips, virtual assistant, and telehealth.
All participants in all groups will be assessed periodically throughout the eight weeks of intervention. Additionally, follow ups will be made at two, four and six months after the end of the intervention. Equivalent intervals will be applied to the SH-MI group. The following clinical questionnaires and scales will be used:
- Sleep log: It includes self-reported items regarding wake and bedtime, sleep latency and other sleeping habits. It allows the calculation of total sleep time, sleep efficiency and wake time after sleep onset. Fille daily.
- Morningness and Eveningness Questionnaire: It evaluates chronotype based on 19 items, allowing categorizing the participants according to the following categories: morning type (definitive or moderate), intermediate, or evening type (definitive or moderate). Applied once, in the first week of follow up.
- Insomnia Severity Index: It evaluates the presence and severity of insomnia, categorizing the participants according to the following categories: no, mild, moderate or severe insomnia. Applied once every two weeks.
- Epworth Sleepiness Scale: It evaluates excessive daytime sleepiness by inquiring about the chance of sleeping in eight daily situations. Scores higher than 10 indicates excessive daytime sleepiness. Applied once every two weeks.
- Pittsburgh Sleep Quality Index: It evaluates overall sleep quality based on 19 self-reported items. Scores higher than 5 indicates poor sleep quality. Applied once every two weeks.
- Sleep Hygiene Index: It habits related to sleep hygiene, based on 13 self-reported items.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
São Paulo
-
São Caetano Do Sul, São Paulo, Brazil, 09530-250
- SleepUp Tecnologia em Saúde LTDA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Literate Brazilian portuguese speakers.
- Insomnia symptoms (as measured by ISI).
- An Android-based smartphone or tablet with access to the Internet.
Exclusion Criteria:
- Previous experience with CBTi.
- Use of sleeping pills or any other treatment for insomnia for two or more days a week in the last three months.
- Presence of self-reported co-morbidities (hypertension, hyper/hypothyroidism, asthma, bronquitis or other respiratory diseases, rhinitis, epilepsy and other neurological diseases, any psychiatric disease other than depression and anxiety, diabetes) or sleep disoders other than insomnia.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard CBTi (CBTi-S):
This is a positive control group/active comparator, in which standard CBTi (the golden standard behavioral treatment for insomnia) will be made available.
This treatment consists of an eight-week treatment composed by weekly and structured appointments with a board-certified sleep psychologist.
The professionals performing the CBTi sessions will not be part of the research team.
Due to the restriction imposed by the COVID-19 pandemic, the appointments will be made remotely (video calls with psychologists), which have already been proven to be equivalent to the in-person CBTi.
|
This is the gold standard behavioral treatment for insomnia and will be performed by independent board-certified sleep psychologists.
The treatments will last eight weeks and the appointments will be made by video-calls.
|
Placebo Comparator: Minimal intervention - Sleep hygiene (MI-SH):
This group corresponds to a negative control group/placebo comparator, subjected to minimal intervention.
It is based on the delivery of informative material regarding normal sleep pattern and sleep hygiene (through regular mail and e-mail).
This procedure is more adequate as a control than the commonly used no-treatment or waiting list controls, due to the behavioral nature of insomnia.
|
It is composed by educational material about normal sleep pattern and sleep hygiene.
It will be delivered by regular mail and email.
|
Experimental: Online CBTI (CBTI-O)
This group will receive access to an eight-month CBTi-based treatment through the SleepUp app.
The platform will be updated into a non-commercial version, and all features other than the CBTi track, the sleep log and the clinical tests will be removed.
This way, the participants of this group will receive interventions equivalent to the standard in-person CBTi, but provided through a digital platform.
The treatment last eight weeks.
|
The CBTi-O and CBTi-O+ interventions are based on real life user experience.
The users will have access to different versions of the platform.
The intervention will last eitght weeks.
|
Experimental: Online CBTi + additional features (CBTi-O+)
This group will have access to the complete premium version of SleepUp platform.
It includes those presented in the CBTi-O group and other therapeutic and complementary features (including meditation audios and videos, mindfulness therapy, relaxation soundtracks, sleep hygiene tips, virtual assistant, and telehealth.
|
The CBTi-O and CBTi-O+ interventions are based on real life user experience.
The users will have access to different versions of the platform.
The intervention will last eitght weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to the treatment
Time Frame: On the completion of the intervention (average: 8 weeks)
|
It will be measured as the percentage of participants who completed the treatment, out of those who effectively initiated it.
Dropouts will be considered whenever a participants fail to comply with the tasks relative to each group for two consecutive weeks, or postpone the completion of these tasks for three times.
These tasks refer to the responses to periodic questionnaires and to the completion of the CBTi or CBTi-O sessions (when applicable).The aim of this comparison is to evaluate whether the adherence rate in the CBTi-O and CBTi-O+ groups are similar to the standard treatment (CBTi-S) or higher than the minimal treatment (SL-MI).
|
On the completion of the intervention (average: 8 weeks)
|
Response to treatment
Time Frame: On the baseline and on the completion of the intervention (average: 8 weeks)
|
Patients are considered to be responsive to treatment if the ISI score is at least 7 points lower than on the basal evaluation.
|
On the baseline and on the completion of the intervention (average: 8 weeks)
|
Remission of symptoms
Time Frame: On the completion of the intervention (average: 8 weeks)
|
Patients are considered to be with no symptoms of insomnia if the ISI score is lower then 8.
|
On the completion of the intervention (average: 8 weeks)
|
Maintenance of results
Time Frame: 6 months after the end of the treatment.
|
Among those patients who completed the treatment program, maintenance of results will be calculated based on the same metrics of "response to treatment" and "remission of symptoms".
|
6 months after the end of the treatment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to the treatment
Time Frame: 2 weeks after the beginning of the intervention.
|
It will be measured as the percentage of participants who completed the treatment, out of those who effectively initiated it.
Dropouts will be considered whenever a participants fail to comply with the tasks relative to each group for two consecutive weeks, or postpone the completion of these tasks for three times.
These tasks refer to the responses to periodic questionnaires and to the completion of the CBTi or CBTi-O sessions (when applicable).The aim of this comparison is to evaluate whether the adherence rate in the CBTi-O and CBTi-O+ groups are similar to the standard treatment (CBTi-S) or higher than the minimal treatment (SL-MI).
|
2 weeks after the beginning of the intervention.
|
Adherence to the treatment
Time Frame: 4 weeks after the beginning of the intervention.
|
It will be measured as the percentage of participants who completed the treatment, out of those who effectively initiated it.
Dropouts will be considered whenever a participants fail to comply with the tasks relative to each group for two consecutive weeks, or postpone the completion of these tasks for three times.
These tasks refer to the responses to periodic questionnaires and to the completion of the CBTi or CBTi-O sessions (when applicable).The aim of this comparison is to evaluate whether the adherence rate in the CBTi-O and CBTi-O+ groups are similar to the standard treatment (CBTi-S) or higher than the minimal treatment (SL-MI).
|
4 weeks after the beginning of the intervention.
|
Adherence to the treatment
Time Frame: 6 weeks after the beginning of the intervention.
|
It will be measured as the percentage of participants who completed the treatment, out of those who effectively initiated it.
Dropouts will be considered whenever a participants fail to comply with the tasks relative to each group for two consecutive weeks, or postpone the completion of these tasks for three times.
These tasks refer to the responses to periodic questionnaires and to the completion of the CBTi or CBTi-O sessions (when applicable).The aim of this comparison is to evaluate whether the adherence rate in the CBTi-O and CBTi-O+ groups are similar to the standard treatment (CBTi-S) or higher than the minimal treatment (SL-MI).
|
6 weeks after the beginning of the intervention.
|
Response to treatment
Time Frame: On the baseline and 2 weeks after the beginning of the intervention.
|
Patients are considered to be responsive to treatment if the ISI score is at least 7 points lower than on the basal evaluation.
|
On the baseline and 2 weeks after the beginning of the intervention.
|
Response to treatment
Time Frame: On the baseline and 4 weeks after the beginning of the intervention.
|
Patients are considered to be responsive to treatment if the ISI score is at least 7 points lower than on the basal evaluation.
|
On the baseline and 4 weeks after the beginning of the intervention.
|
Response to treatment
Time Frame: On the baseline and 6 weeks after the beginning of the intervention.
|
Patients are considered to be responsive to treatment if the ISI score is at least 7 points lower than on the basal evaluation.
|
On the baseline and 6 weeks after the beginning of the intervention.
|
Remission of symptoms
Time Frame: 2 weeks after the beginning of the intervention.
|
Patients are considered to be with no symptoms of insomnia if the ISI score is lower then 8.
|
2 weeks after the beginning of the intervention.
|
Remission of symptoms
Time Frame: 4 weeks after the beginning of the intervention.
|
Patients are considered to be with no symptoms of insomnia if the ISI score is lower then 8.
|
4 weeks after the beginning of the intervention.
|
Remission of symptoms
Time Frame: 6 weeks after the beginning of the intervention.
|
Patients are considered to be with no symptoms of insomnia if the ISI score is lower then 8.
|
6 weeks after the beginning of the intervention.
|
Maintenance of results
Time Frame: 2 months after the end of the treatment.
|
Among those patients who completed the treatment program, maintenance of results will be calculated based on the same metrics of "response to treatment" and "remission of symptoms".
|
2 months after the end of the treatment.
|
Maintenance of results
Time Frame: 4 months after the end of the treatment.
|
Among those patients who completed the treatment program, maintenance of results will be calculated based on the same metrics of "response to treatment" and "remission of symptoms".
|
4 months after the end of the treatment.
|
Sleep quality
Time Frame: 2 weeks after the beginning of the treatment
|
Sleep quality will be measured by the Pittsburgh Sleep Quality Index
|
2 weeks after the beginning of the treatment
|
Sleep quality
Time Frame: 4 weeks after the beginning of the treatment
|
Sleep quality will be measured by the Pittsburgh Sleep Quality Index
|
4 weeks after the beginning of the treatment
|
Sleep quality
Time Frame: 6 weeks after the beginning of the treatment
|
Sleep quality will be measured by the Pittsburgh Sleep Quality Index
|
6 weeks after the beginning of the treatment
|
Sleep quality
Time Frame: On the completion of the treatment
|
Sleep quality will be measured by the Pittsburgh Sleep Quality Index
|
On the completion of the treatment
|
Sleep quality
Time Frame: 2 months after the end of the treatment
|
Sleep quality will be measured by the Pittsburgh Sleep Quality Index
|
2 months after the end of the treatment
|
Sleep quality
Time Frame: 4 months after the end of the treatment
|
Sleep quality will be measured by the Pittsburgh Sleep Quality Index
|
4 months after the end of the treatment
|
Sleep quality
Time Frame: 6 months after the end of the treatment
|
Sleep quality will be measured by the Pittsburgh Sleep Quality Index
|
6 months after the end of the treatment
|
Sleep hygiene
Time Frame: 2 weeks after the beginning of the treatment
|
Sleep hygiene habits will be measured by the Sleep Hygiene Index
|
2 weeks after the beginning of the treatment
|
Sleep hygiene
Time Frame: 4 weeks after the beginning of the treatment
|
Sleep hygiene habits will be measured by the Sleep Hygiene Index
|
4 weeks after the beginning of the treatment
|
Sleep hygiene
Time Frame: 6 weeks after the beginning of the treatment
|
Sleep hygiene habits will be measured by the Sleep Hygiene Index
|
6 weeks after the beginning of the treatment
|
Sleep hygiene
Time Frame: On the completion of the treatment
|
Sleep hygiene habits will be measured by the Sleep Hygiene Index
|
On the completion of the treatment
|
Sleep hygiene
Time Frame: 2 months after the end of the treatment
|
Sleep hygiene habits will be measured by the Sleep Hygiene Index
|
2 months after the end of the treatment
|
Sleep hygiene
Time Frame: 4 months after the end of the treatment
|
Sleep hygiene habits will be measured by the Sleep Hygiene Index
|
4 months after the end of the treatment
|
Sleep hygiene
Time Frame: 6 months after the end of the treatment
|
Sleep hygiene habits will be measured by the Sleep Hygiene Index
|
6 months after the end of the treatment
|
Excessive daytime sleepiness
Time Frame: 2 weeks after the beginning of the treatment
|
Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale
|
2 weeks after the beginning of the treatment
|
Excessive daytime sleepiness
Time Frame: 4 weeks after the beginning of the treatment
|
Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale
|
4 weeks after the beginning of the treatment
|
Excessive daytime sleepiness
Time Frame: 6 weeks after the beginning of the treatment
|
Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale
|
6 weeks after the beginning of the treatment
|
Excessive daytime sleepiness
Time Frame: On the completion of the treatment
|
Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale
|
On the completion of the treatment
|
Excessive daytime sleepiness
Time Frame: 2 months after the end of the treatment
|
Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale
|
2 months after the end of the treatment
|
Excessive daytime sleepiness
Time Frame: 4 months after the end of the treatment
|
Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale
|
4 months after the end of the treatment
|
Excessive daytime sleepiness
Time Frame: 6 months after the end of the treatment
|
Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale
|
6 months after the end of the treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gabriel Pires, PhD, Instituto do Sono
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SleepUp_#01
- 34113520.1.0000.5494 (Other Identifier: Brazilian National Comission of Research Ethics)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Disorder
-
Matrouh UniversitySuez Canal University; Beni-Suef University; University of Bisha, Saudia ArabiaCompletedSleep Disorder | Sleep Hygiene | Sleep Disorder; Insomnia Type | Sleep Disorder in Elderly | Sleep Disorder, Mental Health | Sleep Disorders, Physical HealthEgypt
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedSleep Disorder | Diarrhea | Anxiety Disorders | Insomnia | Sleep Initiation and Maintenance Disorders | Anxiety | Sleep Disturbance | Gastrointestinal Dysfunction | Heartburn | Caffeine | Caffeine Withdrawal | Caffeine; Sleep Disorder | Caffeine Dependence | Caffeine-Induced Anxiety Disorder | Caffeine-Induced Sleep... and other conditionsUnited States
-
Johannes Gutenberg University MainzRecruitingSleep Disorder | Restless Legs Syndrome | Insomnia | Sleep Apnea | Narcolepsy | Idiopathic Hypersomnia | Somnambulism | Sleep Disorder Parasomnia | REM Behavior DisorderGermany
-
Yale UniversityCompletedCircadian Rhythm Sleep Disorder, UnspecifiedUnited States
-
The University of Texas Health Science Center,...Active, not recruitingRapid Eye Movement Sleep Behavior DisorderUnited States
-
Merck Sharp & Dohme LLCCompletedDyssomnias | Sleep Disorders | Mental Disorder | Sleep Initiation and Maintenance Disorder; Elderly | Sleep Disorder, Intrinsic
-
Vanda PharmaceuticalsRecruitingSleep Disorder | Sleep Disturbance | Autism Spectrum Disorder | Neurological DisorderUnited States
-
Assistance Publique Hopitaux De MarseilleAix Marseille UniversitéRecruitingREM Sleep Behaviour DisorderFrance
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingCritical Illness | Sleep Deprivation | Circadian Rhythm Sleep Disorder, UnspecifiedUnited States
-
Massachusetts General HospitalRecruitingRapid Eye Movement Sleep Behavior DisorderUnited States
Clinical Trials on Regular Cognitive Behavioural Therapy for Insomnia
-
Hospital Authority, Hong KongUnknown
-
Universitair Ziekenhuis BrusselUnknownInsomnia | Obstructive Sleep Apnea | Cognitive Behavioral Therapy | Continuous Positive Airway PressureBelgium
-
University of CalgaryUniversity of AlbertaCompleted
-
University of StrathclydeRecruitingQuality of Life | Breast Cancer | Insomnia | Adherence, Medication | SurvivorshipUnited Kingdom
-
University of CalgaryCompletedInsomnia | Post-Concussion Syndrome | Mild Traumatic Brain InjuryCanada
-
The University of Hong KongChinese University of Hong Kong; University of OxfordCompletedDepression | InsomniaHong Kong
-
The University of Hong KongChinese University of Hong Kong; University of Oxford; Flinders UniversityRecruitingInsomnia | Delayed Sleep PhaseHong Kong
-
University of OxfordBig Health Ltd.RecruitingFibromyalgiaUnited Kingdom
-
University of OxfordBig Health Inc.RecruitingStrokeUnited Kingdom
-
Concordia University, MontrealCanadian Institutes of Health Research (CIHR)RecruitingChronic InsomniaCanada